New safety and pharmacokinetic data from Phase 3 C-POST trial provide insights on an every 6-week dosing regimen of adjuvant Libtayo® (cemiplimab) in high-risk cutaneous squamous cell ...
Allied Gold Corporation (TSX: AAUC, NYSE: AAUC) (“Allied” or the “Company”) provides its preliminary operating results for the third quarter ending September 30, 2025. The Company produced over 87,000 ...
The bells are ringing for Windows 10, and many users who have waited are now choosing to update to Windows 11. If you’re one of them, congratulations on continued security updates and new features, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback